Samuel J. Magaziner

Samuel J. Magaziner

Auto-generated profile, based on publicly available information

Samuel J. Magaziner

Center for Human Genetics and Genomics, NYU Grossman School of Medicine, New York, NY

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2023 in Arthritis & Rheumatology
Verified
Journal Article
Open access
Blanka StiburkovaBlanka Stiburkova
Blanka Stiburkova
KPKaterina Pavelcova
Katerina Pavelcova
MBMonika Belickova
Monika Belickova
SMSamuel J. Magaziner
Samuel J. Magaziner
JCJason C. Collins
Jason C. Collins
JVJiri Vencovsky
Jiri Vencovsky
Objective: Somatic mutations in UBA1 have recently been causally linked to a severe adult‐onset inflammatory condition referred to as VEXAS (vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic) syndrome. Ubiquitin‐activating enzyme E1 (UBA‐1) is of fundamental importance to the modulation of ubiquitin homeostasis and to the majority of downstream ubiquitylation‐dependent cellular processes. Direct sequencing analysis of exon 3 containing the prevalent variants p.Met41Leu, p.Met41Val, and/or p.Met41Thr is usually used to confirm the disease‐associated mutations.Methods: We studied the clinical, biochemical, and molecular genetic characteristics of a 59‐year‐old man with a 2‐year history of arthritis, fever, night sweats, nonspecific skin rash, lymphadenopathy, and myelodysplastic syndrome with multilineage dysplasia.Results: The mutational analysis revealed a previously undescribed sequence variant c.1430G>C in exon 14 (p.Gly477Ala) in the gene UBA1. In vitro enzymatic analyses showed that p.Gly477Ala led to both decreased E1 ubiquitin thioester formation and E2 enzyme charging.Conclusion: We report a case of a patient of European ancestry with clinical manifestations of VEXAS syndrome associated with a newly identified dysfunctional UBA‐1 enzyme variant. Due to the patient's insufficient response to various immunosuppressive treatments, allogeneic hematopoietic stem cell transplantation was performed, which resulted in significant improvement of clinical and laboratory manifestations of the disease. image

1 May 2019 in Journal of Bacteriology
Verified
Journal Article
Open access
PDF file
SMSamuel J. Magaziner
Samuel J. Magaziner
ZZZiyue Zeng
Ziyue Zeng
BCBihe Chen
Bihe Chen
GSGeorge Salmond
George Salmond
Bacteriophages are obligate intracellular parasites of bacteria. Some bacteriophages can confer novel bacterial phenotypes, including pathogenicity, through horizontal gene transfer (HGT). The pathogenic bacterium Citrobacter rodentium infects mice using mechanisms similar to those employed by human gastrointestinal pathogens, making it an important model organism. Here, we examined the 10 prophages of C. rodentium , investigating their roles in its evolution toward virulence. We characterized ΦNP and ΦSM, two endogenous active temperate bacteriophages likely important for HGT. We showed that the 10 prophages encode predicted virulence factors and are conserved within other intestinal pathogens. Phylogenetic analysis suggested that they represent a conserved family of horizontally acquired enteric-bacterium-associated pathogenic determinants. Consequently, similar analysis of prophage elements in other pathogens might further understanding of their evolution and pathology.

24 December 2019 in mBio
Verified
Journal Article
Open access
CVCarol L. Vinton
Carol L. Vinton
SMSamuel J. Magaziner
Samuel J. Magaziner
KDKimberly A. Dowd
Kimberly A. Dowd
SRShelly J. Robertson
Shelly J. Robertson
EAEmerito Amaro-Carambot
Emerito Amaro-Carambot
JBJason M. Brenchley
Jason M. Brenchley
Immunocompromised individuals often become symptomatic with infections which are normally fairly asymptomatic in healthy individuals. The particular mechanisms that underlie susceptibility to coinfections in human immunodeficiency virus (HIV)-infected individuals are multifaceted. ZIKV and other flaviviruses are sensitive to neutralizing antibodies, whose production can be limited in HIV-infected individuals but are also sensitive to type I interferons, which are expressed at high levels in HIV-infected individuals. Data in this study highlight how individual components of the innate and adaptive immune responses which become perturbed in HIV-infected individuals influence ZIKV infection.

9 October 2025 in Leukemia
Verified
Journal Article
Open access
PDF file
MSMaki Sakuma
Maki Sakuma
AWAmy K. Wang
Amy K. Wang
SMSamuel J. Magaziner
Samuel J. Magaziner
SKSachiko P. Keane
Sachiko P. Keane
MMManja Meggendorfer
Manja Meggendorfer
WWWencke Walter
Wencke Walter
VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a severe inflammatory and hematologic disease caused by somatic mutations in UBA1 . Canonical pathogenic mutations at UBA1 p.Met41 (M41) lead to the loss of the cytoplasmic isoform (UBA1b), while non-canonical mutations outside of M41 (non-M41) result in reduced activity of both nuclear and cytoplasmic isoforms. Studies have reported clinical differences between canonical and non-canonical mutations, but these findings are constrained by small sample sizes and scarcity of genetic studies. In our study, we screened 29,000 individuals for UBA1 variants, referred for a broad range of hematologic diseases, and subjected to 62-gene panel sequencing, identifying 232 patients carrying likely disease-causing mutations. We identified decreased polyubiquitylation in all of the 18 UBA1 variants tested and found differences in H2A/B monoubiquitylation alteration between M41 and non-M41 mutations. Our findings confirm that patients harboring M41 mutations present at most with myelodysplastic neoplasms (MDS) and suggest that M41 mutations generally do not tolerate multiple co-mutations. In contrast, non-M41 mutations are more likely to appear with co-mutations and are detected in patients with hematologic neoplasms other than MDS. Our study establishes that M41 and non-M41 mutations exhibit distinct clinical and biological phenotypes, significantly enhancing UBA1 variant interpretation.

11 June 2026 in Blood
Verified
Journal Article
Closed access
PDF file
PBPaul Breillat
Paul Breillat
SMSamuel J. Magaziner
Samuel J. Magaziner
SCStéphane M. Camus
Stéphane M. Camus
LDLéa Dionet
Léa Dionet
BVBenjamin De Valence
Benjamin De Valence
BTBenjamin Terrier
Benjamin Terrier
VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a severe adult-onset autoinflammatory disease caused by somatic mutations in the UBA1 gene, disrupting cytoplasmic ubiquitin-activating enzyme E1 function in hematopoietic progenitors. Its pathogenesis remains poorly understood, particularly the mechanisms by which UBA1 mutations disrupt myeloid cell function in the context of inflammatory stimuli. Here, we combine a genetically engineered THP-1 monocytic model with ex vivo analyses of blood and tissue samples from patients with VEXAS syndrome to investigate the consequences of the canonical UBA1M41V mutation. We show that UBA1-mutated monocytes exhibit tumor necrosis factor α (TNF-α)–induced cell death, characterized by receptor-interacting serine/threonine-protein kinase 1 (RIPK1) phosphorylation, and mixed lineage kinase domain-like– and caspase-8–mediated cell death. Importantly, we extend these findings to patient-derived CD14+ sorted cells, confirming that these cells undergo aberrant apoptotic and necroptotic cell death. Mechanistically, activation of these cell death pathways appears to be promoted by defective NF-κB–dependent transcriptional responses and reduced cFLIP(L) expression following TNF-α stimulation. UBA1-mutated monocytes also display blunted cytokine responses to Toll-like receptor (TLR) agonists despite preserved TLR expression, linked to an impaired NF-κB response. UBA1M41V-derived macrophages exhibit a proinflammatory transcriptional profile with increased chemokine secretion that promotes monocyte recruitment. In addition, these UBA1-mutated macrophages display impaired efferocytosis due to lysosomal dysfunction. Together, these findings reveal a pathogenic axis in VEXAS syndrome linking UBA1 loss of function and defective ubiquitination to RIPK1-mediated inflammatory cell death, impaired antimicrobial signaling, and defective resolution mechanisms. Our study provides novel mechanistic insights into the myeloid dysfunction underlying inflammation and cytopenia in VEXAS syndrome and supports the therapeutic targeting of inflammatory cell death pathways.

6 June 2025 in Nature Reviews Rheumatology
Verified
Journal Article
Closed access
PDF file
SMSamuel J. Magaziner
Samuel J. Magaziner
DBDavid B Beck
David B Beck